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Abstract
Background: The cachexia-anorexia syndrome impacts on patients' physical independence and
quality of life. New treatments are required and need to be evaluated using acceptable and reliable
outcome measures, e.g. the assessment of muscle function. The aims of this study were to: (i)
examine the acceptability and reliability of the Cybex NORM dynamometer to assess muscle
function in people with non-small cell lung cancer or mesothelioma; (ii) compare muscle function
in this group with healthy volunteers and; (iii) explore changes in muscle function over one month.
Methods: The test consisted of 25 repetitions of isokinetic knee flexion and extension at maximal
effort while seated on a Cybex NORM dynamometer. Strength and endurance for the quadriceps
and hamstrings were assessed as peak torque and total work and an endurance ratio respectively.
Thirteen patients and 26 volunteers completed the test on three separate visits. Acceptability was
assessed by questionnaire, reliability by intraclass correlation coefficients (ICC) and tests of
difference compared outcomes between and within groups.
Results:  All subjects found the test acceptable. Peak torque and work done were reliable
measures (ICC >0.80), but the endurance ratio was not. Muscle function did not differ significantly
between the patient and a matched volunteer group or in either group when repeated after one
month.
Conclusion: For patients with non-small cell lung cancer or mesothelioma, the Cybex NORM
dynamometer provides an acceptable and reliable method of assessing muscle strength and work
done. Muscle function appears to be relatively well preserved in this group and it appears feasible
to explore interventions which aim to maintain or even improve this.
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Background
The cachexia-anorexia syndrome is common in people
with thoracic cancer impacting upon their activities of
daily living, physical independence and quality of life
[1,2]. Generally, treatment is reactive, when symptoms are
well established, e.g. corticosteroids and progestins, but
these have a catabolic effect which may accelerate the
decline in muscle function [3,4]. New treatments are
required.
Our group is working to develop proactive interventions
such as exercise therapies which could be offered to
patients soon after diagnosis, when they are most likely to
have a reasonable performance status and limited weight
loss, with the aim of preserving physical independence for
as long as possible. These interventions would have a par-
ticular focus on maintaining the performance of the main
muscles of ambulation, i.e. the quadriceps and ham-
strings. Evaluation of these interventions requires an
acceptable and reliable method of assessing leg muscle
function, particularly endurance, as this is probably of
greater functional relevance than strength [5,6]. The
Cybex NORM dynamometer (Cybex, division of Lumex,
Inc., Ronkonkoma, New York, USA) has been used to
assess leg muscle function in healthy volunteers and vari-
ous patient groups, but it has not been widely used in peo-
ple with cancer, particularly thoracic cancer [7-9]. Thus,
we have examined the acceptability and reliability of the
Cybex NORM dynamometer to assess aspects of muscle
function in people with non-small cell lung cancer or
mesothelioma, a good performance status and limited
weight loss. To examine for any early evidence of muscle
function impairment in patients despite a reasonable per-
formance status, we also studied a group of healthy volun-
teers, matched for sex, age and physical activity behaviour.
To begin to explore the rate of decline in muscle function
we repeated the test after one month.
Methods
Subjects
Patients with non-small cell lung cancer or mesothelioma
and an Eastern Co-operative Oncology Group (ECOG)
performance status of 0 or 1 were recruited from respira-
tory or oncology outpatient clinics. Patients were ineligi-
ble if they had weight loss ≥ 10% of their normal body
weight, pain or pathology preventing leg exercise (e.g.
arthritis, peripheral vascular disease, ischaemic heart dis-
ease), chronic obstructive pulmonary disease, radio- or
chemotherapy within the previous month or medication
changes within the previous week. Healthy volunteers
were recruited from the staff and volunteers at Hayward
House. All subjects gave written informed consent and
Nottingham City Hospital Ethics Committee approved
the study (ref. EC02/123).
Measurements
Acceptability
Assessed following the first two visits by a questionnaire
which asked if the subject would be prepared to repeat the
test and also invited open comments about the test. If sub-
jects indicated that they were not prepared to repeat the
test or provided negative comments, further details were
requested.
Physical activity behaviour
Assessed by the 12-item Modified Baecke Questionnaire
which summarizes habitual physical household, sporting
and leisure activities in the last year. Scoring takes into
account the net energy cost of the activity and a higher
score indicates a higher level of activity. A mean (range)
score of 14 (1–31) has been reported in healthy older
adults [10].
Muscle function
Assessed using a Cybex NORM dynamometer situated in
the Human Performance Laboratory at City Hospital
Campus, Nottingham University Hospitals NHS Trust.
Subjects were seated in a chair with a lumbar back support
and straps at the level of the shoulders, pelvis and thighs
to minimize unwanted movement. The padded lever arm
of the dynamometer was placed on the shin of the domi-
nant leg, i.e. the one the subject would kick a ball with,
and attached with straps. The contra-lateral limb was sta-
bilized with a padded support. The seat was adjusted so
that the anatomical axis of rotation of the knee joint was
aligned with the axis of rotation of the dynamometer. The
maximal range of movement at the knee joint was set with
safety stops placed at the extremes of extension and flex-
ion (Figure 1).
Equipment set up and test settings were standardized for
each subject during all test visits. The dynamometer was
set up to only allow isokinetic exercise, i.e. for any force
exerted the machine produced an equivalent resistance
and thus the lower leg could only move at a prefixed
speed. The following measures of muscle function were
obtained using the data capture and analysis software
(version 2.06) provided with the dynamometer:
Strength – peak torque (Newtons, N) during 25 repeti-
tions of flexion and extension was used to indicate the
maximum strength of the hamstrings and quadriceps
respectively.
Endurance – assessed using absolute and relative parame-
ters:
Absolute – the sum of work done for all 25 repetitions.
Work, expressed in Joules (J), equals torque (N) multi-
plied by the angular displacement (radians) and repre-BMC Palliative Care 2008, 7:3 http://www.biomedcentral.com/1472-684X/7/3
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sents the area under the torque curve for each direction of
movement for all repetitions [11].
Relative – work performed in the last 5 repetitions was
divided by the work performed in the first 5 repetitions
and expressed as a percentage to obtain an endurance
ratio. This provides an indication of the subject's ability to
maintain the initial workload [11].
Protocol
Subjects attended on three separate days, 48 h and one
month apart. Each visit was at the same time of day and
lasted 30 min. Subjects were asked to avoid caffeine drinks
within one hour, large meals within two hours and excess
alcohol the night before the tests. Each test began with a
warm up period of 10 min walking at a normal pace.
While seated in the Cybex, subjects performed five sub-
maximal extensions and flexions for familiarization pur-
poses [12]. Subjects then performed 25 repetitions at
180° sec-1 at maximal effort; this is considered sufficient
exercise to assess endurance [12,13]. Standardized verbal
encouragement was given to all subjects by the same
researcher (CM). No visual feedback or advice on tech-
nique was given.
Analysis
Data were assessed for normality and expressed as mean
and standard-deviation or median and interquartile range
as appropriate. Data from the first and second visits for
patients and all volunteers were combined and used to
assess between day reliability of muscle function out-
comes, expressed as the standard deviation of the differ-
ence between tests and the intraclass correlation
coefficient with 95% confidence intervals (values <0.6
indicate poor reliability) [14]. To examine for differences
between patients and volunteers, muscle function out-
comes achieved on the first visit were compared between
patients and a subgroup of volunteers, matched as closely
as possible for age, sex and Modified Baecke Score, using
either the Student's t-test or the Wilcoxon signed-rank test
as appropriate. To examine for change in muscle function
over one month, subject outcomes for the second and
third visits were similarly compared. Calculations were
performed using Statistical Package for the Social Sciences
(SPSS) version 14.0. A p value of <0.05 was regarded as
statistically significant.
Results
Sixteen patients and 28 healthy volunteers were recruited.
Two patients and two volunteers did not complete the
study due to unexpected deterioration or illness respec-
tively in the intervening month; one patient's data was
lost because of technical failure (Table 1). Eight and five
patients respectively had a diagnosis of non-small cell
lung cancer or mesothelioma, local (stage II (3)/III (5)) or
metastatic disease, and a performance status of 0 or 1. Six
patients had received palliative chemotherapy, five radio-
and chemotherapy and one radiotherapy. None had
undergone surgical resection. Median (range) body mass
index was 27 (19–31) kg/m2 and percentage weight loss
was 1 (-7–5) %. To date, 12 have died with a median sur-
vival of 51 (range 10–114) weeks.
Acceptability
All subjects reported that they found the test acceptable
and completed all tests. Two subjects reported minor dis-
comfort from the strap around the leg (one patient) or the
Table 1: Patient and volunteer details.
Patients Matched volunteers All volunteers
Number 13 13 26
Sex (M:F) 6:7 6:7 10:16
Mean (SD) age 63 (6) 63 (6) 59 (9)
Mean (SD) Modified Baecke Questionnaire 12 (7) 11 (5) 13 (11)
Cybex NORM dynamometer set up Figure 1
Cybex NORM dynamometer set up. The anatomical 
axis of rotation of the knee joint was aligned with the 
machine's axis of rotation and safety stops placed at the 
extremes of extension and flexion.BMC Palliative Care 2008, 7:3 http://www.biomedcentral.com/1472-684X/7/3
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contra-lateral limb stabilizer (one volunteer). All subjects
indicated that they would be prepared to complete the test
again.
Reliability
Intraclass correlation coefficient values of >0.8 were
obtained for peak torque (muscle strength) and work
done (absolute parameter of endurance) in both the ham-
strings and quadriceps muscles. The endurance ratios (rel-
ative parameter of endurance) were a less reliable measure
with intraclass correlation coefficient values of <0.6
(Table 2).
Difference in muscle function between patients and 
matched volunteers
Compared to volunteers, patients produced a lower peak
torque, did less work and had a higher endurance ratio for
both the quadriceps and hamstrings, but the differences
were not significant (Table 3).
Difference in muscle function in patients and matched 
volunteers over time
After one month, peak torque, work done or endurance
ratio for the quadriceps or hamstrings did not differ signif-
icantly in either the patient or matched volunteer group
(Table 4).
Discussion
We have demonstrated that leg exercise on a Cybex
NORM dynamometer, involving extension and flexion at
the knee joint, is generally acceptable to patients with
non-small cell lung cancer or mesothelioma and produces
reliable measures of peak torque (strength) and work
done but not of an endurance ratio. Others have also
found absolute parameters more reliable than relative
parameters when assessing muscle endurance [12,13,15].
Compared to age, sex and physical activity behaviour
matched volunteers, there was a tendency for patients to
produce lower values of peak torque and work. We could
find no similar study to directly compare our findings to,
but reduced levels of work have been found in patients
with small cell lung cancer, all in remission, six weeks
after completing chemoradiation therapy when compared
to healthy volunteers [16]. Differences in cancer type,
treatment received and methodology may all contribute
to the variance in the findings. For example, a different
exercise protocol was used and patients and volunteers do
not appear to have been matched for physical activity
behaviour [16]. We also found that the endurance ratio
was higher in the patient group compared to the matched
volunteers. One possible explanation is that despite
standardized encouragement, patients did not work as
hard in the first five compared to the last five repetitions
and thus appear to have fatigued less than the volunteers.
Alternatively, it may reflect the unreliability of the endur-
ance ratio. However, none of the differences in peak
torque, work done or the endurance ratio were statistically
significant. This suggests that muscle function is relatively
well preserved in patients with non-small cell lung cancer
or mesothelioma and a good performance status.
There was a general tendency for the patient group to get
weaker over a period of four weeks, although the changes
were not statistically significant. This period was selected
because it reflects the time generally required for benefit
to become apparent with the types of intervention we
wish to pursue in the future, e.g. exercise training. Longi-
tudinal studies of longer duration are required to identify
the usual rate of decline in this patient group and to help
put into context any benefit achieved with such interven-
tions. Our data can be used to calculate the sample sizes
required for adequately powered studies. For example, a
pilot study examining for benefit of an exercise therapy,
would require a sample size of 36 patients to reliably
detect a change of 20% in peak torque and work done
(80% power, p = 0.05).
Disadvantages to the use of the Cybex Norm Dynamome-
ter include its cost and limited availability. The form of
exercise is also unfamiliar for patients and appropriate
Table 2: Between day reliability of peak torque, work done and endurance ratio in all patients and volunteers (n = 39).
Mean value for the tests Mean difference between the 
tests
SD of the difference between 
tests
Intraclass correlation coefficient 
(95% CI)
Quadriceps
Peak torque (N) 69 9 14 0.91 (0.82–0.95)
Work (J) 1098 125 321 0.84 (0.69–0.92)
Endurance ratio (%) 87 -15 38 0.56 (0.17–0.77)
Hamstrings
Peak torque (N) 42 8 13 0.86 (0.75–0.93)
Work (J) 682 110 197 0.88 (0.77–0.94)
Endurance ratio (%) 102 -14 60 0.49 (0.02–0.74)
SD = standard deviation; CI = confidence intervalBMC Palliative Care 2008, 7:3 http://www.biomedcentral.com/1472-684X/7/3
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familiarization with the equipment is required in order to
achieve a maximal performance [7,17].
We have continued to use the Cybex NORM dynamome-
ter in this group of patients, and are currently exploring
the clinical relevance of measures of peak torque and work
done by comparing them with performance ability in the
incremental and endurance shuttle walking tests and free-
living physical activity levels, assessed by an activity mon-
itor.
Conclusion
Exercise on a Cybex NORM dynamometer is an acceptable
and reliable method of measuring peak torque and work
done in the quadriceps and hamstrings of patients with
lung cancer or mesothelioma and a good performance sta-
tus. Muscle function appears to be relatively well pre-
served in this group, and this provides a window of
opportunity for interventions designed to maintain or
even improve muscle function, e.g. exercise training.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
AW conceived the study and supervised the research
throughout, made substantial contributions to the analy-
sis and interpretation of data and helped prepare the man-
uscript for publication. MM made substantial
contributions to the analysis and interpretation of data,
performed the statistical analysis and helped revise and
prepare the manuscript for publication. ML, PH, JF, SB,
CM, BeK and HE participated in the coordination of the
study, made substantial contributions the acquisition of
data and helped draft the manuscript. SM helped conceive
the study and co-supervised the research throughout,
made substantial contributions to the analysis and inter-
pretation of data and helped draft the manuscript.
Acknowledgements
We would like to acknowledge with gratitude the inspiration and drive 
given to this project by Simon Mockett who sadly died unexpectedly in Sep-
tember 2007.
We thank all patients and volunteers who took part in this study and Tricia 
McKeever and Sarah Lewis for statistical advice. This project received fund-
ing from Hayward House Cancer Care Trust, Nottingham City Hospital 
Research and Development Pump Priming Fund, the Association of Pallia-
tive Medicine/Napp Research Bursary and the Mason Medical Foundation.
References
1. Muscaritoli M, Bossola M, Aversa Z, Bellantone R, Fanelli FR: Preven-
tion and treatment of cancer cachexia: New insights into an
old problem.  European J of Cancer 2006, 42:31-41.
2. O'Gorman P, McMillan DC, McArdle CS: Impact of weight loss,
appetite, and the inflammatory response on quality of life in
gastrointestinal cancer patients.  Nutr Cancer 1998, 32:76-80.
3. Lambert CP, Sullivan DH, Freeling SA, Lindquist DM, Evans WJ:
Effects of testosterone replacement and/or resistance exer-
cise on the composition of megestrol acetate stimulated
Table 4: Change in peak torque, work done and endurance ratio 
in the quadriceps and hamstrings over one month. Values are 
mean (SD) except when given as median [inter-quartile range].
Visit 2 Visit 3 p value
Patients (n = 13)
Quadriceps
Peak torque (N) 63 (26) 58 (27) ns
Work (J) 916 (459) 973 (493) ns
Endurance ratio (%) 73 [62–84] 77 [68–93] ns
Hamstrings
Peak torque (N) 41 (21) 30 (14) ns
Work (J) 612 (280) 501 (279) ns
Endurance ratio (%) 92 [79–103] 87 [83–99] ns
Matched volunteers (n = 13)
Quadriceps
Peak torque (N) 73 (21) 75 (25) ns
Work (J) 1262 (341) 1160 (370) ns
Endurance ratio (%) 76 [69–93] 77 [68–91] ns
Hamstrings
Peak torque (N) 46 (26) 47 (18) ns
Work (J) 752 (202) 708 (265) ns
Endurance ratio (%) 85 [74–108] 86 [67–91] ns
Table 3: Difference between peak torque, work done and endurance ratio in patients and matched volunteers. Values are median 
[inter-quartile range].
Patients (n = 13) Matched volunteers (n = 13) p value
Quadriceps
Peak torque (N) 65 [27–71] 74 [54–84] ns
Work (J) 821 [576–1386] 1057 [960–1393] ns
Endurance ratio (%) 84 [72–108] 75 [70–90] ns
Hamstrings
Peak torque (N) 32 [13–39] 48 [36–54] ns
Work (J) 515 [167–706] 721 [540–902] ns
Endurance ratio (%) 95 [91–164] 88 [79–120] nsPublish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Palliative Care 2008, 7:3 http://www.biomedcentral.com/1472-684X/7/3
Page 6 of 6
(page number not for citation purposes)
weight gain in elderly men: A randomized controlled trial.  J
Clin Endocrinol Metab 2002, 87:2100-2106.
4. Montovani G: The current management of cancer cachexia.  In
Cachexia and wasting: a modern approach Edited by: Italy: Springer-Ver-
lag Italia. Montovani G; 2006:563-579. 
5. Coronell C, Orozco-Levi M, Mendez R, Ramirez-Sarmiento A, Galdiz
JB, Gea J: Relevance of assessing quadriceps endurance in
patients with COPD.  Eur Respir J 2004, 24:129-136.
6. Kostka T, Rahmani A, Berthouze SE, Lacour J-R, Bonnefoy M: Quad-
riceps muscle function in relation to habitual physical activ-
ity and VO2 max in men and women aged more than 65
years.  J Gerontol 2000, 55A:B481-B488.
7. Frontera WR, Hughes VA, Dallal GE, Evans WJ: Reliability of isok-
inetic muscle strength testing in 45-to-78-year-old men and
women.  Arch Phys Med Rehabil 1993, 74:1181-1185.
8. Madsen OR, Lauridsen UB: Knee extensor and flexor strength in
elderly women after recent hip fracture: assessment by the
Cybex 6000 dynamometer of intra-rater inter-test reliabil-
ity.  Scand J Rehabil Med 1995, 27:219-226.
9. Imprellizzeri FM, Bizzini M, Rampinino E, Cereda F, Maffiuletti NA:
Reliability of isokinetic strength imbalance ratios measured
using the Cybex NORM dynamometer.  Clin Physiol Funct Imaging
2008, 28:113-119.
10. Voorrips LE, Ravelli ACJ, Dongelmans PCA, Deurenberg P, Van Stav-
eren WA: A physical activity questionnaire for the elderly.
Med Sci Sports Exerc 1991, 23:974-979.
11. Cybex Norm: Cybex Norm testing and rehabilitation system: User's guide
Blue Sky Software Corporation, Ronkonkoma, New York; 1996. 
12. Kannus P: Isokinetic evaluation of muscular performance:
Implications for muscle testing and rehabilitation.  Int J Sports
Med 1994, 15:s11-s18.
13. Kannus P, Cook L, Alosa D: Absolute and relative endurance
parameters in isokinetic tests of muscular performance.  Jour-
nal of Sport Rehab 1992, 1:2-12.
14. Chinn S: Repeatability and method comparison.  Thorax 1991,
46:454-456.
15. Gleeson NP, Mercer TH: Reproducibility of isokinetic leg
strength and endurance characteristics of adult mean and
women.  Eur J App Phys 1992, 65(3):221-228.
16. Baracos VE, Urtasun RC, Humen DP, Haennel RG: Physical fitness
of patients with small cell lung cancer.  Clin J Sport Med 1994,
4:223-227.
17. Osternig LR: Isokinetic dynamometry: Implications for muscle
testing and rehabilitation.  Exerc Sport Sci Rev 1986, 14:45-80.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1472-684X/7/3/prepub